Healthcare, globally, is struggling to provide equitable access to treatment, improve outcomes and contain costs.
Managing primary care practice in today’s clinical setting is challenging. One in 4 primary care patients in North America is prescribed at least 1 medication that commonly causes adverse drug reactions due to genetic variability in drug metabolism. At CQuentia, we understand that identifying potential adverse drug events prior to their onset and prescribing medications appropriate for the patient’s physiology is a critical determinant of your clinical success.
Find out what other leading institutions are saying about CQuentia.
Our comprehensive PGx panel, developed incorporating the guidelines laid by the Clinical Pharmacogenetics Implementation Consortium (CPIC) in our CLIA-certified laboratory, further identifies a patient’s risk of malignant hyperthermia or thrombotic risk during hospitalization. Combining medication efficacy with genetic factors will provide you with a greater level of patient detail that is needed to deliver Precision Medicine.
CQuentia, more than a lab, more than a test. The leaders in the new frontier of genomics testing and personalized medicine.